![1390PEfficacy of anamorelin in advanced non-small cell lung cancer (NSCLC) patients with anorexia/cachexia and modified Glasgow Prognostic Score (mGPS) of 2: Pooled analysis of two phase 3 trials]()
1390PEfficacy of anamorelin in advanced non-small cell lung cancer (NSCLC) patients with anorexia/cachexia and modified Glasgow Prognostic Score (mGPS) of 2: Pooled analysis of two phase 3 trialsKaasa, S.; Laird, B.; Fallon, M.; McMillan, D.; Skipworth, R.; Currow, D.; Giorgino, R. · Annals of Oncology · 2017